Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
3,158,681
-
Shares change
-
+3,154,885
-
Total reported value, excl. options
-
$18,681,000
-
Value change
-
+$18,658,021
-
Number of buys
-
6
-
Price
-
$5.92
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2014
As of 31 Dec 2014 Aptose Biosciences Inc. - Common Shares had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,158,681 shares of stock of the company.
Largest 7 holders included FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, BVF INC/IL, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, and UBS Group AG.
This table shows 7 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.